Pain Patients Have Difficulty Getting OxyContin October 2, 2001
News Summary
Because of the growing nationwide misuse of OxyContin, many physicians are no longer prescribing the potent prescription painkiller, leaving patients without a drug that is effective in treating their chronic pain, the Associated Press reported Oct. 1.Sally Royster of Ohio recently learned that her orthopedic surgeon would no longer prescribe OxyContin for her chronic back pain. She and other chronic pain sufferers are finding OxyContin difficult to obtain because of the controversy surrounding the drug.
In recent months, misuse of OxyContin has skyrocketed, with more than 100 deaths nationwide related to the drug. In addition, pharmacies are being robbed by addicted individuals looking for the drug.
"I have seen abuse reach epidemic proportions in other states and I don't want that to happen in Vermont," said Vermont Gov. Howard Dean, a physician. The state has asked doctors to find substitutes for OxyContin and ordered pharmacies to remove it from their shelves.
With lawmakers and law enforcement stepping in, doctors have become less willing to prescribe the drug. In Vermont, for instance, the state no longer pays for OxyContin unless patients have terminal cancer or sickle-cell anemia. The same restrictions hold true in South Carolina, although the state will pay for the drug for AIDS patients.
Alabama, Florida, Maine, Michigan, Mississippi, North Carolina, and West Virginia also limit the amount of OxyContin a patient on Medicaid can receive in a month without approval.
"They're treating everyone who is sick enough to be prescribed OxyContin as if they were a criminal suspect," said Kent Willis, a spokesman for the Virginia chapter of the American Civil Liberties Union.
Chronic pain sufferers say OxyContin provides a 12-hour release from their suffering; other pain medicines last only four hours. "Anything that restricts a patient's access to what their physician feels is the appropriate amount or level of treatment has the potential to interfere with medical care," said James Heins, spokesman for Purdue Pharma, which manufactures the drug.
COMMENTS ON THIS ARTICLE: